Related references
Note: Only part of the references are listed.Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
Ela Araz Server et al.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY (2019)
EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma
Matthew Yung et al.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY (2017)
Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity
Mahmood A. Hamed et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2017)
A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction
Robert K. Jackler et al.
LARYNGOSCOPE (2015)
Keratin 17: A Critical Player in the Pathogenesis of Psoriasis
Liang Jin et al.
MEDICINAL RESEARCH REVIEWS (2014)
Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study
V. Akdogan et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2013)
Elevated Level of Tenascin and Matrix Metalloproteinase 9 Correlates With the Bone Destruction Capacity of Cholesteatomas
Attila Juhasz et al.
OTOLOGY & NEUROTOLOGY (2009)
Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis
MA Huisman et al.
ACTA OTO-LARYNGOLOGICA (2003)
Share Paper
